OBJECTIVE: Colorectal cancer incidence is greater among African Americans, compared to whites in the U.S., and may be due in part to differences in diet, genetic variation at metabolic loci, and/or the joint effect of diet and genetic susceptibility. We examined whether our previously reported associations between meat-derived heterocyclic amine (HCA) intake and colon cancer were modified by N-acetyltransferase 1 (NAT1) or 2 (NAT2) genotypes and whether there were differences by race. METHODS: In a population-based, case-control study of colon cancer, exposure to HCAs was assessed using a food-frequency questionnaire with a meat-cooking and doneness module, among African Americans (217 cases and 315 controls) and whites (290 cases and 534 controls). RESULTS: There was no association with NAT1*10 versus NAT1-non*10 genotypes for colon cancer. Among whites, there was a positive association for NAT2-"rapid/intermediate" genotype [odds ratio (OR)=1.4; 95% confidence interval (CI)=1.0, 1.8], compared to the NAT2-"slow" that was not observed among African Americans. Colon cancer associations with HCA intake were modified by NAT1, but not NAT2, regardless of race. However, the "at-risk" NAT1 genotype differed by race. For example, among African Americans, the positive association with 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) was confined to those with NAT1*10 genotype (OR=1.8; 95% CI=1.0, 3.3; P for interaction=0.02, comparing highest to lowest intake), but among whites, an association with 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) was confined to those with NAT1-non*10 genotype (OR=1.9; 95% CI=1.1, 3.1; P for interaction=0.03). CONCLUSIONS: Our data indicate modification by NAT1 for HCA and colon cancer associations, regardless of race. Although the at-risk NAT1 genotype differs by race, the magnitude of the individual HCA-related associations in both race groups are similar. Therefore, our data do not support the hypothesis that NAT1 by HCA interactions contribute to differences in colorectal cancer incidence between African Americans and whites.
OBJECTIVE:Colorectal cancer incidence is greater among African Americans, compared to whites in the U.S., and may be due in part to differences in diet, genetic variation at metabolic loci, and/or the joint effect of diet and genetic susceptibility. We examined whether our previously reported associations between meat-derived heterocyclic amine (HCA) intake and colon cancer were modified by N-acetyltransferase 1 (NAT1) or 2 (NAT2) genotypes and whether there were differences by race. METHODS: In a population-based, case-control study of colon cancer, exposure to HCAs was assessed using a food-frequency questionnaire with a meat-cooking and doneness module, among African Americans (217 cases and 315 controls) and whites (290 cases and 534 controls). RESULTS: There was no association with NAT1*10 versus NAT1-non*10 genotypes for colon cancer. Among whites, there was a positive association for NAT2-"rapid/intermediate" genotype [odds ratio (OR)=1.4; 95% confidence interval (CI)=1.0, 1.8], compared to the NAT2-"slow" that was not observed among African Americans. Colon cancer associations with HCA intake were modified by NAT1, but not NAT2, regardless of race. However, the "at-risk" NAT1 genotype differed by race. For example, among African Americans, the positive association with 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) was confined to those with NAT1*10 genotype (OR=1.8; 95% CI=1.0, 3.3; P for interaction=0.02, comparing highest to lowest intake), but among whites, an association with 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) was confined to those with NAT1-non*10 genotype (OR=1.9; 95% CI=1.1, 3.1; P for interaction=0.03). CONCLUSIONS: Our data indicate modification by NAT1 for HCA and colon cancer associations, regardless of race. Although the at-risk NAT1 genotype differs by race, the magnitude of the individual HCA-related associations in both race groups are similar. Therefore, our data do not support the hypothesis that NAT1 by HCA interactions contribute to differences in colorectal cancer incidence between African Americans and whites.
Authors: Jessie Satia-Abouta; Joseph A Galanko; John D Potter; Alice Ammerman; Christopher F Martin; Robert S Sandler Journal: Am J Epidemiol Date: 2003-11-15 Impact factor: 4.897
Authors: Jessie Satia-Abouta; Joseph A Galanko; Christopher F Martin; John D Potter; Alice Ammerman; Robert S Sandler Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-08 Impact factor: 4.254
Authors: Christoph Sachse; Gillian Smith; Murray J V Wilkie; Jennifer H Barrett; Robin Waxman; Frank Sullivan; David Forman; D Timothy Bishop; C Roland Wolf Journal: Carcinogenesis Date: 2002-11 Impact factor: 4.944
Authors: J H Barrett; G Smith; R Waxman; N Gooderham; T Lightfoot; R C Garner; K Augustsson; C R Wolf; D T Bishop; D Forman Journal: Carcinogenesis Date: 2003-02 Impact factor: 4.944
Authors: L M Butler; R Sinha; R C Millikan; C F Martin; B Newman; M D Gammon; A S Ammerman; R S Sandler Journal: Am J Epidemiol Date: 2003-03-01 Impact factor: 4.897
Authors: Loïc Le Marchand; Jean H Hankin; Lisa M Pierce; Rashmi Sinha; Pratibha V Nerurkar; Adrian A Franke; Lynne R Wilkens; Laurence N Kolonel; Timothy Donlon; Ann Seifried; Laurie J Custer; Annette Lum-Jones; Wendy Chang Journal: Mutat Res Date: 2002-09-30 Impact factor: 2.433
Authors: Hugo Girard; Lesley M Butler; Lyne Villeneuve; Robert C Millikan; Rashmi Sinha; Robert S Sandler; Chantal Guillemette Journal: Mutat Res Date: 2008-07-16 Impact factor: 2.433
Authors: M Elizabeth Hodgson; Andrew F Olshan; Kari E North; Charles L Poole; Donglin Zeng; Chiu-Kit Tse; Tope O Keku; Joseph Galanko; Robert Sandler; Robert C Millikan Journal: Int J Mol Epidemiol Genet Date: 2012-11-15
Authors: Jenna Voutsinas; Lynne R Wilkens; Adrian Franke; Thomas M Vogt; Lance A Yokochi; Robert Decker; Loïc Le Marchand Journal: Gut Date: 2012-05-24 Impact factor: 23.059
Authors: S D Ramsey; R S Holmes; C L McDermott; D K Blough; K L Petrin; E M Poole; C M Ulrich Journal: Colorectal Dis Date: 2012-09 Impact factor: 3.788
Authors: Anne M J Gilsing; Sonja I Berndt; Elizabeth H Ruder; Barry I Graubard; Leah M Ferrucci; Laura Burdett; Joel L Weissfeld; Amanda J Cross; Rashmi Sinha Journal: Carcinogenesis Date: 2012-05-02 Impact factor: 4.944